Targeting TET3 in macrophages provides a concept strategy for the treatment of endometriosis is a research paper published in Journal of Clinical Investigation (2024). On theSindex it has a DataRank of 0. It has been cited 3 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NICHD NIH HHS
Grant: R01 HD102170
NICHD NIH HHS
Grant: P01 HD106485
NICHD NIH HHS
Grant: R01 HD108895
NICHD NIH HHS
Grant: R01 HD101243
National Institutes of Health
Grant: 5R01HD102170-06
Epigenetic regulation of receptive endometrium
National Institutes of Health
Grant: 5P01HD106485-02
Collaborative Center to Develop Improved Diagnostic and Therapeutic Approaches to Endometriosis
National Institutes of Health
Grant: 5R01HD108895-04
Development of anti-inflammatory nanodrug for endometriosis treatment
National Institutes of Health
Grant: 7R01HD101243-04
Molecular mechanisms of endometrial progesterone resistance
FWCI
1.20
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals